Kilitch Drugs (India) Limited Financial Overview
Kilitch Drugs (India) Limited's market cap is currently ₹5.80B. The company's EPS TTM is ₹4.97; its P/E ratio is 20.12; Kilitch Drugs (India) Limited is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
